Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVEETA: Autologous Ex Vivo Expanded Erythroblast Transplantation for Chronic Critical Limb Ischemia
jRCTb030190188Completed
- Start
- Feb 2018
- Countries
- 1
01
Overview
Open-label, single-arm trial in chronic limb-threatening ischemia (CLTI) and arteriosclerosis obliterans. Primary endpoint: Change in skin perfusion pressure. Started Feb 2018; status: completed.
02
Conditions
chronic limb-threatening ischemia (CLTI)arteriosclerosis obliterans
Beyond the preview
Go deeper on jRCTb030190188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb030190188.